S21-382 Potential First-In-Class Neuroprotective Agents and Therapeutic Target for Treatment of Glaucoma; Optic Neuropathies The Hu Lab at Stanford has identified several FDA-approved small molecule medicines with neuroprotective effects on glaucoma. Yang Hu Wei Chen
S08-441 Oligocarbonate molecular transporters across biological barriers Stanford University researchers have developed a new family of oligocarbonate molecular transporters (OMTs) that penetrate cell membranes and tissues. Paul Wender Robert Waymouth James Hedrick Fredrik Nederberg Christina Cooley Brian Trantow Matthew Kiesewetter